Results 101 to 110 of about 3,524 (151)

HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina. [PDF]

Retrovirology, 2020
Benencio P, Fraile Gonzalez SA, Ducasa N, Page K, Berini CA, Biglione MM.   +5 more
europepmc   +1 more source

Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. [PDF]

Front Microbiol, 2019
Tamaki K, Sato T, Tsugawa J, Fujioka S, Yagishita N, Araya N, Yamauchi J, Coler-Reilly ALG, Nagasaka M, Hasegawa Y, Yamano Y, Tsuboi Y.   +11 more
europepmc   +1 more source

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan. [PDF]

Orphanet J Rare Dis, 2019
Tsutsumi S, Sato T, Yagishita N, Yamauchi J, Araya N, Hasegawa D, Nagasaka M, Coler-Reilly ALG, Inoue E, Takata A, Yamano Y.   +10 more
europepmc   +1 more source

Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. [PDF]

BMC Infect Dis, 2019
Queiroz GAN, Mascarenhas REM, Vieillard V, Andrade RL, Galvão-Castro B, Grassi MFR.   +5 more
europepmc   +1 more source

Hodgkin-like adult T-cell leukemia/lymphoma that developed during the follow-up of HTLV-1 associated myelopathy/tropical spastic paraparesis. [PDF]

J Clin Exp Hematop, 2019
Nakaya Y, Yoshida M, Tsutsumi M, Fuseya H, Horiuchi M, Yoshimura T, Hayashi Y, Nakao T, Koh KR, Niino D, Inoue T, Yamane T.   +11 more
europepmc   +1 more source

An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis. [PDF]

Retrovirology, 2019
Mozhgani SH, Piran M, Zarei-Ghobadi M, Jafari M, Jazayeri SM, Mokhtari-Azad T, Teymoori-Rad M, Valizadeh N, Farajifard H, Mirzaie M, Khamseh A, Rafatpanah H, Rezaee SA, Norouzi M.   +13 more
europepmc   +1 more source

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity. [PDF]

Front Microbiol, 2018
Sato T, Yagishita N, Tamaki K, Inoue E, Hasegawa D, Nagasaka M, Suzuki H, Araya N, Coler-Reilly A, Hasegawa Y, Tsuboi Y, Takata A, Yamano Y.   +12 more
europepmc   +1 more source

HTLV-1 proviral load in infective dermatitis associated with HTLV-1 does not increase after the development of HTLV-1-associated myelopathy/tropical spastic paraparesis and does not decrease after IDH remission. [PDF]

PLoS Negl Trop Dis, 2019
Batista ES, Oliveira PD, Primo J, Varandas CMN, Nunes AP, Bittencourt AL, Farre L.   +6 more
europepmc   +1 more source

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. [PDF]

PLoS One, 2016
Nozuma S, Matsuura E, Matsuzaki T, Watanabe O, Kubota R, Izumo S, Takashima H.   +6 more
europepmc   +1 more source

Tropical spastic paraparesis and polymyositis: a still unfolding story

West Indian Medical Journal, 2006
openaire   +2 more sources